Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Moderna, Inc. (MRNA) Price & Performance

Heron Therapeutics IncTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Moderna, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Moderna, Inc. trades at $60.73 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 393.4× Heron Therapeutics Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXMRNA
Market Cap
$61.47M$24.18B
Sector
HealthHealth
52-Week High
$1.49$81.80
52-Week Low
$0.32$22.36
Enterprise Value
$168.21M$20.33B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA